NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

TEM

Tempus AI Inc

May 20 • 04:00PM ET

62.43

Dollar change -1.31
Percentage change -2.06	%

Healthcare • Health Information Services • USA • NASD

Peers: ILMN EXAS GH TXG CRSP PACB NTLA EDIT CDNA TWST

| Held by: ARKK VTI VB ARKG VBK IBB JTEK ROBT IPO THNQ

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.60	Insider Own	46.69%	Shs Outstand	167.99M	Perf Week	-9.40%
Market Cap	10.81B	Forward P/E	-	EPS next Y	-0.01	Insider Trans	-11.82%	Shs Float	92.29M	Perf Month	52.34%
Income	-721.31M	PEG	-	EPS next Q	-0.23	Inst Own	32.93%	Short Float	20.56%	Perf Quarter	-27.16%
Sales	803.32M	P/S	13.45	EPS this Y	55.27%	Inst Trans	10.08%	Short Ratio	1.56	Perf Half Y	10.24%
Book/sh	1.89	P/B	33.12	EPS next Y	97.88%	ROA	-70.47%	Short Interest	18.97M	Perf Year	-
Cash/sh	1.26	P/C	49.40	EPS next 5Y	-	ROE	-	52W Range	22.89 - 91.45	Perf YTD	84.92%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-32.48%	ROI	-61.41%	52W High	-31.73%	Beta	-
Dividend TTM	-	Quick Ratio	1.56	Sales past 5Y	39.44%	Gross Margin	55.42%	52W Low	172.74%	ATR (14)	5.47
Dividend Ex-Date	Jul 18, 2006	Current Ratio	1.71	EPS Y/Y TTM	-160.27%	Oper. Margin	-87.17%	RSI (14)	57.09	Volatility	8.19% 8.88%
Employees	2400	Debt/Eq	2.63	Sales Y/Y TTM	42.93%	Profit Margin	-89.79%	Recom	2.07	Target Price	64.91
Option/Short	Yes / Yes	LT Debt/Eq	2.60	EPS Q/Q	27.16%	Payout	-	Rel Volume	1.20	Prev Close	63.74
Sales Surprise	3.07%	EPS Surprise	7.69%	Sales Q/Q	75.38%	Earnings	May 06 AMC	Avg Volume	12.16M	Price	62.43
SMA20	7.01%	SMA50	22.28%	SMA200	21.03%	Trades		Volume	14,874,200	Change	-2.06%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-21-25	Initiated	BTIG Research	Buy	$60
Feb-25-25	Downgrade	JP Morgan	Overweight → Neutral	$50 → $55
Feb-12-25	Downgrade	William Blair	Outperform → Mkt Perform
Feb-05-25	Resumed	TD Cowen	Buy	$58 → $74
Dec-13-24	Initiated	Wolfe Research	Outperform	$60
Dec-09-24	Initiated	Guggenheim	Buy	$74
Nov-11-24	Downgrade	Stifel	Buy → Hold	$45 → $65
Oct-02-24	Downgrade	BofA Securities	Buy → Neutral	$45 → $60
Aug-12-24	Initiated	Piper Sandler	Neutral	$40
Jul-09-24	Initiated	William Blair	Outperform
Jul-09-24	Initiated	TD Cowen	Buy	$50
Jul-09-24	Initiated	Stifel	Buy	$45
Jul-09-24	Initiated	Needham	Buy	$47
Jul-09-24	Initiated	Morgan Stanley	Overweight	$44
Jul-09-24	Initiated	Loop Capital	Buy	$48
Jul-09-24	Initiated	Longbow	Buy	$48
Jul-09-24	Initiated	JP Morgan	Overweight	$42
Jul-09-24	Initiated	BofA Securities	Buy	$41

Show Previous Ratings

May-20-25 11:39AM	Tempus partners with Verastem for companion diagnostic development (Medical Device Network)
11:15AM	These 3 AI-Related Stocks Crushed Earnings (Zacks)
08:30AM	Tempus Announces a Collaboration with Verastem to Develop CDx for First-Ever FDA-Approved KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer Combination Treatment (Business Wire)
07:33AM	From Retina Scans to Cancer Trials, AI Is Taking Over the Exam Room (PR Newswire)
May-19-25 11:16AM	Should You be Confident in Tempus AI (TEM)? (Insider Monkey)
03:00PM	Loading…
May-15-25 03:00PM	After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order? (Zacks)
04:48AM	Boehringer partners Tempus AI to enhance cancer therapy pipeline (Pharmaceutical Technology)
May-14-25 08:30AM	Tempus Enters Multi-Year Strategic Collaboration With Boehringer Ingelheim to Advance Its Cancer Pipeline (Business Wire) -5.99%
May-13-25 07:40PM	Why Tempus AI Inc. (TEM) Skyrocketed On Tuesday (Insider Monkey) +9.92%
04:05PM	Tempus Announces Six Posters Accepted for Presentation at ISPOR 2025 (Business Wire)
11:34AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (and Sold) (Motley Fool)
11:11AM	Is Tempus AI, Inc. (TEM) the Best Performing Healthcare Stock to Buy Now? (Insider Monkey)
06:45AM	Tradr Launches First Leveraged ETF on Tempus AI (PR Newswire)
May-10-25 09:50AM	Jim Cramer Says Stay Away from This Nancy Pelosi Stock (Insider Monkey)
07:00AM	MarketBeat Week in Review - 05/05 - 05/09 (MarketBeat)
11:30AM	Loading…
May-09-25 11:30AM	These AI Stocks Posted Robust Results: Time to Buy? (Zacks) -5.90%
May-08-25 07:45AM	Tempus AI Stock: Time to Double Down or Cut and Run? (MarketBeat) +10.99%
01:48AM	Why Tempus AI, Inc. (TEM) Skyrocketed On Wednesday (Insider Monkey)
May-07-25 12:34PM	Q1 2025 Tempus AI Inc Earnings Call (Thomson Reuters StreetEvents) +12.59%
07:49AM	Tempus AI, Inc. (TEM): Among Most Popular Stocks on Robinhood in 2025 (Insider Monkey)
03:22AM	Tempus AI Inc (TEM) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
May-06-25 04:01PM	Tempus Reports First Quarter 2025 Results (Business Wire)
May-05-25 05:07PM	Jim Cramer Warns on Tempus AI (TEM): "Diagnostics With no Dough? I'm Out" (Insider Monkey) -5.24%
12:35PM	AI Healthcare Boom Gains Speed as Regulators and Innovators Align (PR Newswire)
08:30AM	Tempus Announces Notetaker, its AI-Powered Clinical Assistant for Psychiatry (Business Wire)
May-02-25 08:58AM	Think It's Too Late to Buy Tempus AI? Here's the Biggest Reason Why There's Still Time. (Motley Fool) +10.05%
05:32AM	Tempus selects TIME Network for Phase I clinical trials (Clinical Trials Arena)
May-01-25 11:04AM	New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty (PR Newswire)
08:30AM	Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment (Business Wire)
Apr-30-25 05:32AM	Is This the Best Nancy Pelosi Stock to Buy After a 40% Pullback? (Motley Fool)
08:45AM	Loading…
Apr-29-25 08:45AM	Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth (GlobeNewswire)
08:30AM	Tempus Publishes Study Validating the Benefits of xF+, its Comprehensive Liquid Biopsy Assay for Therapy Selection (Business Wire)
Apr-28-25 03:00PM	Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings? (Zacks)
08:30AM	Tempus Introduces Loop, an AI-Powered Target Discovery and Validation Platform (Business Wire)
Apr-26-25 02:04PM	Why Tempus AI Inc. (TEM) Soared Last Week (Insider Monkey)
Apr-25-25 08:30AM	Tempus Announces 18 Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025 (Business Wire)
07:29AM	Tempus AI, AstraZeneca, and Pathos AI join forces on cancer care (Pharmaceutical Business Review)
04:49AM	The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS (Zacks)
Apr-24-25 03:00PM	Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal? (Zacks) +7.97%
08:30AM	Tempus to Report First Quarter 2025 Financial Results on May 6 (Business Wire)
07:33AM	AstraZeneca enters $200m AI cancer pact with Tempus and Pathos (Pharmaceutical Technology)
Apr-23-25 07:59PM	Tempus AI, Inc. (TEM): A Bull Case Theory (Insider Monkey) +14.62%
06:16PM	Why Tempus AI Inc. (TEM) Went Up On Wednesday (Insider Monkey)
02:01PM	Tempus AI Is Skyrocketing Today -- Is the Stock a Buy Right Now? (Motley Fool)
01:26PM	Is Tempus AI, Inc. (TEM) the Best Nancy Pelosi Stock To Invest In Now? (Insider Monkey)
10:48AM	Why Tempus AI Stock Is Skyrocketing Today (Motley Fool)
08:00AM	Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology (Business Wire)
Apr-22-25 09:47AM	Tempus AI (TEM) Initiated at 'Buy' with $60 Price Target by BTIG (Insider Monkey) +5.49%
06:34AM	Tempus AI: Cooldown Arrived (Rating Upgrade) (Seeking Alpha)
Apr-21-25 03:04PM	Tempus AI Gets Bullish Boost from BTIG on Data Strength, Expansion Moves (GuruFocus.com)
Apr-20-25 10:20AM	Tempus: The AI Engine Powering Healthcare (Seeking Alpha)
Apr-18-25 08:30AM	Tempus Unveils Advisory Board Featuring Leading Physicians From Across the U.S. (Business Wire)
05:00AM	Illumina, Tempus AI partner to drive genomic testing beyond cancer (MedTech Dive)
Apr-16-25 08:45AM	Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations (GlobeNewswire)
Apr-15-25 09:15AM	Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation (PR Newswire)
Apr-14-25 10:49AM	3 Hot New IPOs Defying the 2025 Market Slump (MarketBeat)
Apr-11-25 03:00PM	Tempus AI vs. Doximity: Which AI in Healthcare Stock is a Better Buy? (Zacks)
Apr-10-25 03:00PM	Beyond Tempus AI: 2 Health IT Stocks Poised for Growth in 2025 (Zacks) -7.99%
Apr-09-25 06:15AM	Why Tempus AI Inc. (TEM) Went Down On Tuesday? (Insider Monkey) +17.62%
Apr-04-25 07:15PM	Tempus AI, Inc. (TEM): Among Stocks That Will Profit From AI (Insider Monkey) -7.78%
Apr-01-25 03:00PM	Tempus AI Surges 43% YTD: Is it the Right Time to Invest in the Stock? (Zacks)
Mar-30-25 07:10AM	abrdn World Healthcare Fund Q4 2024 Commentary (Seeking Alpha)
03:25AM	abrdn Healthcare Opportunities Fund Q4 2024 Commentary (Seeking Alpha)
Mar-29-25 08:30AM	Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting (Business Wire)
07:15AM	4 Healthcare Stocks With Massive Gains-and More to Come (MarketBeat)
Mar-27-25 03:55AM	Why Tempus AI Inc. (TEM) Crashed On Wednesday? (InsiderMonkey)
Mar-26-25 10:58AM	Is Tempus AI Inc. (NASDAQ:TEM) the Best AI Stock to Invest in According to Reddit? (InsiderMonkey) -9.08%
08:30AM	Tempus to Present at the 24th Annual Needham Virtual Healthcare Conference (Business Wire)
Mar-25-25 08:45AM	AI Influence on Medical Diagnostics Generating Billion Dollar Revenues While Growing Adoption Reduces Healthcare Costs (GlobeNewswire)
08:30AM	Tempus AI's Valuation Bakes In Strong Growth - A Hold For Now (SeekingAlpha)
Mar-24-25 11:49PM	Tempus AI Inc. (TEM)Among Cathie Wood's Top AI Stock Picks in 2025 (InsiderMonkey) +14.90%
Mar-22-25 03:15AM	Why Tempus AI (TEM) Went Up On Friday? (InsiderMonkey)
Mar-19-25 02:13PM	Tap Billion-Dollar AI Opportunity in Oncology: Stocks in the Spotlight (Zacks) +5.01%
Mar-17-25 09:08AM	Tempus AI (TEM) Expands Precision Medicine Capabilities with Deep 6 AI Acquisition (Insider Monkey) +5.72%
Mar-16-25 10:17PM	Tempus AI, Inc. (TEM): Among Top Insider Sales Last Month (Insider Monkey)
Mar-14-25 10:10AM	Is Tempus AI, Inc. (TEM) the Best Performing Growth Stock in 2025? (Insider Monkey) +11.87%
Mar-11-25 05:15PM	Tempus Announces Acquisition of Deep 6 AI (Business Wire)
10:09AM	Why Tempus AI (TEM) Shares Are Soaring: The Cathie Wood Effect (Insider Monkey)
Mar-07-25 10:00PM	Why Does Nancy Pelosi Like Tempus AI (TEM) Stock So Much? (Benzinga) -8.00%
09:10PM	Tempus AI, Inc. (TEM): Among The Stocks With At Least $10 Million In Insider Sales Recently (Insider Monkey)
Mar-05-25 11:20AM	JPMorgan Downgrades Tempus AI, Inc. (TEM) to Neutral Despite Positive 2025 Guidance (Insider Monkey)
Mar-03-25 03:33PM	Analyst says AI stock picked by Cathie Wood will surge (TheStreet) -9.34%
Mar-02-25 06:20AM	Street Calls of the Week (Investing.com)
Feb-27-25 06:26PM	Tempus AI, Inc. (TEM) Reaffirmed as Buy with Strong Growth Outlook (Insider Monkey) -11.18%
12:04PM	SCOPE 2025: investors share optimism and obstacles for AI in clinical operations (Pharmaceutical Technology)
Feb-26-25 05:47PM	Cathie Wood buys $27 million of tumbling AI stock (TheStreet) +5.35%
12:27PM	Why Tempus AI, Inc. (TEM) Went Down on Tuesday (Insider Monkey)
11:10AM	Ark Invest Buys the Dip as Cathie Wood Snaps Up Tempus AI Shares (GuruFocus.com)
10:00AM	Tempus AI Stock Has Soared 108% Already in 2025; Is It a Buy Now? (Motley Fool)
Feb-25-25 04:22PM	Tempus AI Reverses 192% Run. Why At Least One Analyst Remains A Believer. (Investor's Business Daily) -15.05%
03:38PM	Tempus AI, Inc. (TEM) Reports Strong Q4 Growth, Fueled by AI-Driven Diagnostics (Insider Monkey)
03:32PM	Stock Market Today: Dow Jones Improves; Tesla Skids Again While Techs Keep Tumbling (Live Coverage) (Investor's Business Daily)
11:07AM	Stock Market Today: Dow Jones, S&P 500 Fall; Hims & Hers Tanks, Bitcoin Falls (Live Coverage) (Investor's Business Daily)
11:05AM	Tempus AI Costs, Outlook Send Stock Sharply Lower (Investopedia)
10:31AM	Q4 2024 Tempus AI Inc Earnings Call (Thomson Reuters StreetEvents)
10:05AM	JP Morgan cuts Tempus AI rating to neutral after stocks sharp rally (Investing.com)
09:29AM	Tempus AI, Inc. (TEM) and Menarini Group Leverage AI to Advance Breast Cancer Care (Insider Monkey)
02:03AM	Tempus AI Inc (TEM) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Moves (GuruFocus.com)
Feb-24-25 05:36PM	Tempus Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
05:23PM	Tempus AI Stock Drops After Company Posts Q4 Results (Investor's Business Daily)

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
RYAN BARTOLUCCI	Officer	May 20 '25	Proposed Sale	63.74	1,819	115,943		May 20 04:32 PM
ANDREW POLOVIN	Officer	May 20 '25	Proposed Sale	63.74	7,755	494,304		May 20 04:31 PM
JAMES ROGERS	Officer	May 20 '25	Proposed Sale	63.74	11,708	746,268		May 20 04:31 PM
Leonsis Theodore	Director	May 09 '25	Sale	66.26	770	51,020	43,550	May 13 04:15 PM
REVOLUTION GROWTH III, LP	Shareholder	May 09 '25	Proposed Sale	65.22	770	50,219		May 09 04:18 PM
Fukushima Ryan	Chief Operating Officer	May 06 '25	Sale	52.36	20,000	1,047,239	884,460	May 08 04:30 PM
Epstein David R	Director	May 01 '25	Sale	53.50	370	19,795	25,914	May 05 04:15 PM
Gottlieb Scott	Director	Apr 01 '25	Sale	47.21	27,837	1,314,154	32,839	Apr 03 05:30 PM
Doudna Jennifer A	Director	Apr 01 '25	Sale	48.12	625	30,075	25,740	Apr 03 04:15 PM
Fukushima Ryan	Chief Operating Officer	Apr 01 '25	Sale	47.20	20,000	944,085	904,460	Apr 03 04:15 PM
Frederick Wayne A.I.	Director	Mar 31 '25	Sale	45.54	3,000	136,620	26,514	Apr 02 06:13 PM
RYAN FUKUSHIMA	Officer	Apr 01 '25	Proposed Sale	48.24	60,000	2,894,400		Apr 01 04:22 PM
Polovin Andrew	EVP and General Counsel	Mar 21 '25	Sale	50.00	3,076	153,800	151,095	Mar 25 04:15 PM
ANDREW POLOVIN	Officer	Mar 21 '25	Proposed Sale	48.04	3,076	147,771		Mar 21 04:21 PM
Rogers James William	Chief Financial Officer	Mar 18 '25	Sale	45.97	23,030	1,058,699	164,750	Mar 19 06:30 PM
Polovin Andrew	EVP and General Counsel	Mar 18 '25	Sale	45.98	13,135	603,970	154,171	Mar 19 06:30 PM
Epstein David R	Director	Mar 17 '25	Sale	46.83	990	46,362	26,284	Mar 19 06:30 PM
West Nadja	Director	Mar 17 '25	Sale	48.86	7,634	372,962	30,071	Mar 19 06:30 PM
Gottlieb Scott	Director	Mar 17 '25	Sale	48.85	27,838	1,359,989	60,676	Mar 19 06:30 PM
Frederick Wayne A.I.	Director	Mar 17 '25	Sale	48.85	9,000	439,659	29,514	Mar 19 06:30 PM
Doudna Jennifer A	Director	Mar 17 '25	Sale	48.80	9,308	454,210	26,365	Mar 19 06:30 PM
ANDREW POLOVIN	Officer	Mar 18 '25	Proposed Sale	49.87	13,135	655,042		Mar 18 04:41 PM
JAMES ROGERS	Officer	Mar 18 '25	Proposed Sale	49.87	23,030	1,148,506		Mar 18 04:27 PM
WAYNE FREDERICK	Director	Mar 17 '25	Proposed Sale	47.17	12,000	566,040		Mar 17 04:47 PM
DAVID R. EPSTEIN	Director	Mar 17 '25	Proposed Sale	47.17	1,610	75,944		Mar 17 04:25 PM
SCOTT GOTTLIEB	Director	Mar 17 '25	Proposed Sale	47.17	55,675	2,626,190		Mar 17 04:23 PM
LEFKOFSKY ERIC P	CEO and Chairman	Mar 05 '25	Sale	50.93	562,345	28,641,725	9,457,283	Mar 07 04:56 PM
LEFKOFSKY ERIC P	CEO and Chairman	Mar 06 '25	Sale	49.83	250,000	12,457,454	9,407,283	Mar 07 04:56 PM
Fukushima Ryan	Chief Operating Officer	Mar 04 '25	Sale	51.15	20,000	1,022,974	924,460	Mar 06 05:05 PM
West Nadja	Director	Mar 04 '25	Sale	51.11	809	41,347	37,705	Mar 06 05:05 PM
Eric P. Lefkofsky	Officer	Mar 05 '25	Proposed Sale	52.73	662,345	34,925,452		Mar 05 05:44 PM
Doudna Jennifer A	Director	Mar 03 '25	Sale	57.52	338	19,442	35,673	Mar 05 04:15 PM
Epstein David R	Director	Mar 03 '25	Sale	57.52	250	14,380	27,274	Mar 05 04:15 PM
NADJA WEST	Director	Mar 04 '25	Proposed Sale	50.93	8,443	430,002		Mar 04 05:08 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 27 '25	Sale	58.75	3,240,234	190,363,748	0	Feb 27 07:39 PM
Lightbank Investments 1B, LLC	Affiliate	Feb 27 '25	Proposed Sale	59.10	115,751	6,840,884		Feb 27 04:27 PM
Innovation Group Investors, L.	Affiliate	Feb 27 '25	Proposed Sale	59.10	1,580,928	93,432,845		Feb 27 04:26 PM
Lightbank Global, LLC	Affiliate	Feb 27 '25	Proposed Sale	59.10	1,397,589	82,597,510		Feb 27 04:25 PM
Innovation Group Investors, L.	Affiliate	Feb 27 '25	Proposed Sale	59.10	145,966	8,626,591		Feb 27 04:24 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 19 '25	Sale	80.87	84,640	6,844,680	4,964,820	Feb 20 07:55 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 20 '25	Sale	74.09	69,231	5,129,325	4,895,589	Feb 20 07:55 PM
Fukushima Ryan	Chief Operating Officer	Feb 19 '25	Sale	81.87	2,868	234,814	944,460	Feb 20 07:55 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 20 '25	Sale	80.00	1,682	134,560	44,500	Feb 20 07:55 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 19 '25	Sale	81.87	818	66,973	46,182	Feb 20 07:55 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Feb 18 '25	Sale	82.36	61,582	5,072,077	153,080	Feb 20 07:55 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Feb 19 '25	Sale	81.87	903	73,932	152,177	Feb 20 07:55 PM
Polovin Andrew	EVP and General Counsel	Feb 18 '25	Sale	82.32	64,381	5,299,820	172,857	Feb 20 07:55 PM
Polovin Andrew	EVP and General Counsel	Feb 19 '25	Sale	81.87	5,551	454,470	167,306	Feb 20 07:55 PM
Rogers James William	Chief Financial Officer	Feb 18 '25	Sale	82.33	31,780	2,616,308	189,320	Feb 20 07:55 PM
Rogers James William	Chief Financial Officer	Feb 19 '25	Sale	81.87	1,540	126,086	187,780	Feb 20 07:55 PM
RYAN BARTOLUCCI	Officer	Feb 20 '25	Proposed Sale	85.71	1,682	144,164		Feb 20 04:22 PM
JAMES ROGERS	Officer	Feb 18 '25	Proposed Sale	89.44	31,780	2,842,403		Feb 18 04:29 PM
ANDREW POLOVIN	Officer	Feb 18 '25	Proposed Sale	89.44	64,381	5,758,237		Feb 18 04:29 PM
ERIK PHELPS	Officer	Feb 18 '25	Proposed Sale	89.44	61,582	5,507,894		Feb 18 04:28 PM
Doudna Jennifer A	Director	Feb 14 '25	Sale	90.00	1,320	118,800	36,011	Feb 14 07:53 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 14 '25	Sale	85.78	80,003	6,862,467	5,049,460	Feb 14 04:33 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 13 '25	Sale	78.51	78,594	6,170,792	5,129,463	Feb 14 04:33 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 12 '25	Sale	70.02	84,948	5,948,059	5,208,057	Feb 14 04:33 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 13 '25	Sale	80.00	6,059	484,720	47,000	Feb 14 04:32 PM
JENNIFER A DOUDNA	Director	Feb 14 '25	Proposed Sale	83.75	11,253	942,439		Feb 14 04:23 PM
RYAN BARTOLUCCI	Officer	Feb 13 '25	Proposed Sale	73.88	6,059	447,639		Feb 13 04:31 PM
LEFKOFSKY ERIC P	Officer	Feb 12 '25	Proposed Sale	71.21	535,000	38,097,350		Feb 12 08:21 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Feb 05 '25	Sale	67.57	5,934	400,960	214,662	Feb 07 05:38 PM
Polovin Andrew	EVP and General Counsel	Feb 05 '25	Sale	67.57	7,717	521,438	237,238	Feb 07 05:36 PM
Rogers James William	Chief Financial Officer	Feb 05 '25	Sale	67.57	8,712	588,670	221,100	Feb 07 05:35 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 06 '25	Sale	71.00	2,320	164,720	53,059	Feb 07 05:34 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 05 '25	Sale	67.57	1,858	125,545	55,379	Feb 07 05:34 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 06 '25	Sale	67.89	85,109	5,778,114	5,373,393	Feb 07 05:33 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 07 '25	Sale	67.53	80,388	5,428,398	5,293,005	Feb 07 05:33 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 05 '25	Sale	67.53	74,485	5,030,067	5,458,502	Feb 07 05:33 PM
Fukushima Ryan	Chief Operating Officer	Feb 04 '25	Sale	62.50	20,000	1,250,033	962,442	Feb 06 06:02 PM
Fukushima Ryan	Chief Operating Officer	Feb 05 '25	Sale	67.57	15,114	1,021,253	947,328	Feb 06 06:02 PM
RYAN BARTOLUCCI	Officer	Feb 06 '25	Proposed Sale	69.18	2,320	160,498		Feb 06 04:23 PM
Epstein David R	Director	Feb 03 '25	Sale	53.31	370	19,725	27,524	Feb 05 06:06 PM
Bartolucci Ryan M	Chief Accounting Officer	Jan 31 '25	Sale	60.00	13,770	826,200	57,237	Jan 31 09:26 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jan 31 '25	Sale	58.21	82,056	4,776,799	5,532,987	Jan 31 09:23 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jan 29 '25	Sale	53.86	79,118	4,261,125	5,692,669	Jan 31 09:23 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jan 30 '25	Sale	54.63	77,626	4,240,708	5,615,043	Jan 31 09:23 PM
RYAN BARTOLUCCI	Officer	Jan 31 '25	Proposed Sale	57.19	13,770	787,506		Jan 31 04:34 PM
LEFKOFSKY ERIC P	Officer	Jan 29 '25	Proposed Sale	51.02	520,000	26,530,400		Jan 29 08:44 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jan 23 '25	Sale	52.26	645,068	33,709,713	5,857,575	Jan 24 06:53 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jan 22 '25	Sale	49.84	476,209	23,733,244	6,502,643	Jan 24 06:53 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jan 24 '25	Sale	53.39	85,788	4,580,274	5,771,787	Jan 24 06:53 PM
LEFKOFSKY ERIC P	Officer	Jan 24 '25	Proposed Sale	54.84	85,788	4,704,614		Jan 24 06:50 PM
LEFKOFSKY ERIC P	Officer	Jan 23 '25	Proposed Sale	50.45	645,068	32,543,681		Jan 23 09:14 PM
LEFKOFSKY ERIC P	Officer	Jan 22 '25	Proposed Sale	47.64	476,209	22,686,597		Jan 22 09:29 PM
KEYWELL BRADLEY A	10% Owner	Jan 16 '25	Sale	34.84	510,364	17,781,775	15,483,365	Jan 17 06:15 PM
KEYWELL BRADLEY A	10% Owner	Jan 17 '25	Sale	35.10	265,000	9,302,159	15,218,365	Jan 17 06:15 PM
KEYWELL BRADLEY A	10% Owner	Jan 15 '25	Sale	35.45	170,720	6,052,768	15,993,729	Jan 17 06:15 PM
Fukushima Ryan	Chief Operating Officer	Jan 07 '25	Sale	39.61	20,000	792,192	982,442	Jan 08 04:23 PM
Fukushima Ryan	Chief Operating Officer	Jan 02 '25	Sale	34.66	1,265	43,845	1,002,442	Jan 03 04:52 PM
Fukushima Ryan	Officer	Jan 02 '25	Proposed Sale	33.76	1,265	42,706		Jan 02 07:19 PM
LEFKOFSKY ERIC P	CEO and Chairman	Dec 18 '24	Sale	37.54	187,655	7,045,334	9,557,283	Dec 20 09:00 PM
Rogers James William	Chief Financial Officer	Dec 16 '24	Sale	40.23	1,468	59,058	229,812	Dec 18 08:15 PM
Polovin Andrew	EVP and General Counsel	Dec 16 '24	Sale	40.23	1,130	45,460	244,955	Dec 18 08:15 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Dec 16 '24	Sale	40.23	2,396	96,391	220,596	Dec 18 08:15 PM
Fukushima Ryan	Chief Operating Officer	Dec 16 '24	Sale	40.23	3,500	140,805	1,003,707	Dec 18 08:15 PM
Bartolucci Ryan M	Chief Accounting Officer	Dec 16 '24	Sale	40.23	339	13,638	71,007	Dec 18 08:15 PM
LEFKOFSKY ERIC P	Officer	Dec 18 '24	Proposed Sale	38.95	400,000	15,580,000		Dec 18 05:21 PM
Polovin Andrew	EVP and General Counsel	Dec 11 '24	Sale	42.39	51,504	2,183,187	246,085	Dec 13 06:20 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TEM

Tempus AI Inc

Upgrade your FINVIZ experience